← Back to all trials
Completed
NCT07621627
Peritoneal Transport With a New Bicarbonate-based Peritoneal Dialysis Solution Compared to Conventional Solution.
Conditions: Chronic Renal Failure (CRF), Dialysis Dependent Chronic Kidney Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE3
Enrollment: 7
Sponsor: Karolinska Institutet
Location: Research unit, renal medicine Stockholm
Summary
Cross-over study. Patients treated with peritoneal dialysis are investigated twice with a single 4h dwell study: once with Bicarbonate-Lactate solution as buffer (Physioneal TM) and once with conventional lactate PD solution (Dianeal TM). Radioidinated human serum albumin is used as a volume marker to assess ultrafiltration and frequent dialysis and blood sampling to assess peritneal transport of solutes and pH changes.
Eligibility Criteria
Inclusion Criteria:
* patient treated with peritoneal dialysis in a clinically stable condition
Exclusion Criteria:
* none
Source: ClinicalTrials.gov (NCT07621627). StuddyBuddy aggregates publicly available trial information.
